Navigation Links
Kindred Biosciences Announces Global Sponsorship of International Society of Equine Locomotor Pathology
Date:3/7/2017

SAN FRANCISCO, March 7, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, is proud to announce its partnership with the International Society of Equine Locomotor Pathology (ISELP) by joining their team of Global Sponsors starting in 2017. The partnership with ISELP is part of an initiative by KindredBio to support the education of veterinarians and veterinary students, and to promote the growth and advancement of the equine industry. ISELP is an advanced education program for equine veterinarians to learn the most advanced techniques in diagnostics and treatments for the performance horse.

Kent Allen, DVM, Vice President & Executive Director of ISELP said, "It is a great pleasure to welcome KindredBio to the ISELP family of Global Sponsors. I am thrilled that we have this opportunity. KindredBio fits into our ISELP model because of their leading-edge technology and commitment to excellence in equine healthcare. We look forward to many productive years of collaboration and networking."

KindredBio looks forward to announcing its global sponsorship of the ISELP Student Education Program starting in 2017, which will be made to ISELP members attending the 3-Day meeting in Irving, Texas, March 7-11, 2017.

"The commitment to supporting continuing education of this caliber for equine veterinarians and students is at the core of our culture at KindredBio. We are honored to be partnered with ISELP, an organization at the apex of equine education," said Denise Bevers, Co-Founder and Chief Operating Officer of KindredBio.

About Kindred Biosciences

Kindred Biosciences is a development-stage biopharmaceutical company focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The Company's strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for dogs, cats and horses. The Company has a deep pipeline of novel drugs and biologics in development across many therapeutic classes.

For more information or to download the corporate presentation, visit www.KindredBio.com/LearnMore. Stay connected with KindredBio on Facebook at www.Facebook.com/KindredBio.

About ISELP

"Continuing education of equine practitioners for a better management of patients" Formed in the United States, under the direction of Dr. Jean-Marie Denoix, The International Society of Equine Locomotor Pathology (ISELP) will focus on the problem of lameness in the equine athlete. The goal of ISELP is to provide contemporary knowledge and techniques in the continually evolving field of equine locomotor analysis to better prepare the equine clinician to understand and manage lameness conditions in the equine athlete. Founded in 2006, ISELP is rapidly growing and currently has members on all five continents.

Contact

Russell Radefeld KindredBio russell.radefeld@kindredbio.com (650) 701-7904

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/kindred-biosciences-announces-global-sponsorship-of-international-society-of-equine-locomotor-pathology-300418162.html


'/>"/>
SOURCE Kindred Biosciences, Inc.
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. Kindred Biosciences to Announce Fourth Quarter and Year-End 2015 Financial Results
2. Kindred Biosciences to Provide Corporate Update
3. Kindred Biosciences Announces Second Quarter 2015 Financial Results
4. Kindred Biosciences Announces First Quarter 2015 Financial Results
5. Kindred Biosciences to Present at 2015 Jefferies Animal Health Summit
6. KindredBio to Announce Fourth Quarter and Year-End 2014 Financial Results
7. DuPont Industrial Biosciences Leader Presents Major Advances in Biomaterials at 2017 Advanced Bioeconomy Leadership Conference
8. Luxcel Biosciences and HD Biosciences Enter Collaboration Agreement for Mitochondria Toxicity & Metabolism Assays for Preclinical Drug Safety Evaluation
9. ACEA Biosciences Hires Roger Luo as Vice President of Global Clinical Development
10. Research Reports Coverage on Biotech Stocks -- Anthera Pharma, Arrowhead Pharma, Pacific Biosciences of California, and Conatus Pharma
11. Fluxion Biosciences Appoints Genetracer Biotech of Spain As an Isoflux Liquid Biopsy Certified Service Provider
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... , ... August 18, 2017 , ... ... Equipment for the Semiconductor, MEMS, and Microfluidics Industries, announces the new Model 800E ... found more often in automated production mask aligners. OAI has already received ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... Electrospinning and Electrospraying line of nanofiber and nanoparticle fabrication ... for the lab to fully automated pilot plants and equipment for industrial ...
(Date:8/16/2017)... MN (PRWEB) , ... August 16, 2017 , ... ... our third U.S. Food and Drug Administration (FDA) inspection at our Dilworth, MN ... No 483 was issued. This inspection was conducted as part of a routine ...
(Date:8/15/2017)... ... August 15, 2017 , ... Kapstone Medical ... years of successes helping medical technology companies and inventors develop and safeguard their latest ... full-service national engineering firm with a portfolio of clients in the United States and ...
Breaking Biology Technology:
(Date:4/13/2017)... 13, 2017 UBM,s Advanced Design and Manufacturing ... feature emerging and evolving technology through its 3D Printing ... run alongside the expo portion of the event and ... demonstrations focused on trending topics within 3D printing and ... manufacturing event will take place June 13-15, 2017 at the ...
(Date:4/11/2017)... , April 11, 2017 NXT-ID, ... security technology company, announces the appointment of independent Directors Mr. ... to its Board of Directors, furthering the company,s corporate ... ... NXT-ID, we look forward to their guidance and benefiting from ...
(Date:4/4/2017)... NEW YORK , April 4, 2017   ... solutions, today announced that the United States Patent and ... The patent broadly covers the linking of an iris ... the same transaction) and represents the company,s 45 th ... our latest patent is very timely given the multi-modal ...
Breaking Biology News(10 mins):